Skip to content
Oncology Research Hub

Illinois

Cancer clinical trials in Illinois

467 cancer studies are recruiting participants at sites in 89 cities across Illinois as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Illinois city with a recruiting study

By research area: Lung Cancer (144), Breast Cancer (117), Lymphoma (94), Prostate Cancer (63), Pancreatic Cancer (31), Melanoma (18).

Chicago (337), Peoria (81), Decatur (63), Springfield (61), Urbana (61), O'Fallon (56), Effingham (51), Danville (47), Bloomington (45), Mattoon (45), Ottawa (44), Pekin (44), Galesburg (43), Peru (43), Orland Park (42), Washington (42), Canton (41), Warrenville (41), Carthage (40), Eureka (40), Kewanee (40), Macomb (40), Maywood (40), Princeton (40), DeKalb (36), Geneva (36), Glenview (36), Evanston (35), Park Ridge (33), Oak Lawn (32), Shiloh (32), New Lenox (29), Zion (29), Centralia (27), Dixon (27), Lake Forest (27), Carterville (25), Aurora (24), Grayslake (24), Libertyville (24), Oak Brook (23), Barrington (22), Crystal Lake (22), Downers Grove (22), Hazel Crest (22), Hinsdale (22), Mount Vernon (22), Elgin (21), Normal (21), Rockford (21), Alton (16), Highland Park (16), Naperville (16), Lisle (14), Carbondale (13), Harvey (13), Skokie (13), Elmhurst (12), Niles (10), Arlington Heights (9), Plainfield (9), Hines (8), Moline (8), Oak Park (8), Palos Heights (8), Yorkville (8), Burr Ridge (6), Chicago Ridge (6), Homer Glen (6), Melrose Park (6), Winfield (5), Quincy (4), Huntley (3), North Chicago (3), Elk Grove (2), Elk Grove Village (2), Hoffman Estates (2), Calumet City (1), Champaign (1), Deerfield (1), Evergreen Park (1), Flossmoor (1), Hyde Park (1), Lake Barrington (1), McHenry (1), River Forest (1), Rolling Meadows (1), Swansea (1), Tinley Park (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Illinois

Basic details from each study's public record (the 12 most recently updated of 467). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Skokie
    Registry record
    NCT06324357 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Illinois on ClinicalTrials.gov.

Lung cancer: recently updated in Illinois

  1. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Zion
    Registry record
    NCT06216301 · updated
  2. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chicago · New Lenox · Orland Park
    Registry record
    NCT06287775 · updated
  3. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Zion
    Registry record
    NCT07277413 · updated
  4. A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Recruiting in
    Peoria
    Registry record
    NCT07365319 · updated
  5. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Peoria
    Registry record
    NCT07513376 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Illinois on ClinicalTrials.gov.

Melanoma: recently updated in Illinois

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Burr Ridge · Chicago · Evanston · and 7 more U.S. locations
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Illinois on ClinicalTrials.gov.

Lymphoma: recently updated in Illinois

  1. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Chicago
    Registry record
    NCT05289687 · updated
  2. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Burr Ridge · Homer Glen · Maywood · and 1 more U.S. location
    Registry record
    NCT06724237 · updated
  3. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Swansea
    Registry record
    NCT06806033 · updated
  4. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Chicago
    Registry record
    NCT07221500 · updated
  5. ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Newave Pharmaceutical Inc
    Recruiting in
    Skokie
    Registry record
    NCT07342478 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Illinois on ClinicalTrials.gov.

Ask about studies in Illinois

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call